There are always new and improved techniques and technology in medicine. This is particularly true when it comes to rhinology “the study of the nose”. One needs to be well versed in Facial Plastic Surgery, Allergy and Immunology, Headaches and Facial Pain, and of course the Medical and Surgical treatment of Sinus and Nasal disorders. We owe it to our patients to be the experts in all these areas and be the final consult when it comes to these complaints. Our pledge to you is that we will keep up on any new developments and continue to offer the best and most comprehensive care for our patients.
A new procedure that is like “angioplasty” of the sinuses allows for quicker recovery.
A new procedure allows the correction of nasal valve collapse.
Xolair (Omalizumab) is currently in a phase IV study for the treatment of chronic rhinosinusitis.
Ongoing FDA trials and multiple new studies continue to confirm the efficacy of Sublingual Immunotherapy. Probably partly because of economic pressures Sublingual Immunotherapy continues to face more resistance in the U.S. It is important to note that no one is advocating drops over shots. High dose subcutaneous shots with standardized antigens is clearly the “gold standard”, however, for those not candidates for shots we feel that sublingual immunotherapy may be a good alternative.
Nasal Inhalation of Dornase Alfa (Pulmozyme) in Patients With Cystic Fibrosis and Chronic Rhinosinusitis
CF patients tend to be the most refractory sinus patients.
“Good Bacteria” manufacture B vitamins, aid in digestion, and keep harmful bacteria and fungi at bay.
Using lower dose macrolides for extended duration in the treatment of Chronic Rhinosinusitis is extremely helpful for select patients.
The topical delivery of medications is often greatly facilitated by surgical intervention. Using topical antibiotics, antifungals, steroids, and mucolytics is often the most effective long term treatment. A number of new devices facilitates delivery of these agents.
We have hundreds of before and after photos for your review in the clinic. Also see ourrhinoplasty gallery section. Chin implants can accentuate the benefits of a rhinoplasty.
Experimental Treatment for Hay Fever Shows Promising Results
Morphing software allows patients to more accurately relate their desired outcomes for facial plastic procedures.
Academic excellence and credentialing are paramount for safe and effective allergy care
Xoponex has been introduced as the new Albuterol.
ALK-Abello successfully launched a grass pill last year. The studies and clinical success are impressive. It also underscores the efficacy of oral immunotherapy.
Supplements and Nutrition can be extremely helpful in the Sinus and Allergy patient.
Eosinophilic Esophagitis seems to represent the end point of allergies affecting the Gastrointestinal Tract.
Asthma seems to be the endpoint of Allergic Inflammation of the lower Respiratory Tract.
Are Reactions to Contrast Media Allergic?